Insulin Glargine Injection, Long-Acting: References

BASAGLAR (insulin glargine injection), for subcutaneous use. Eli Lilly and Company. Drugs@FDA. US Food and Drug Administration. Accessed January 19, 2016 from http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205692lbl.pdf

Toujeo (insulin glargine injection), U-300, for subcutaneous use. sanofi-aventis US LLC. Accessed January 19, 2016 from http://products.sanofi.us/toujeo/toujeo.pdf

LANTUS (insulin glargine injection) solution for subcutaneous injection. sanofi-aventis U.S. LLC. Accessed January 19, 2016 from http://products.sanofi.us/lantus/lantus.html

Insulin Glargine. Lexi-Comp ONLINE, 2016 Lexi-Comp, Inc. Accessed January 19, 2016 from http://online.lexi.com.

Insulin Glargine. DRUGDEX System. 2016 Truven Health Analytics Inc. Accessed January 19, 2016 from http://www.thomsonhc.com